KPA's official statement on manipulated bio equivalency tests.

Published: 2006-05-02 06:59:00

Updated: 2006-05-02 06:59:00

The Korea Pharmaceutical Association (KPA) announced an official statement on April 26 over the late KFDA's case report of the bio equivalency test fraud covering that the unfortunate incidence should make a critical momentum for the government drug administration level to be one step upgraded
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK